Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the ...

Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company announced a ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

More National Guard troops are heading soon to Washington, D.C., and they are preparing to start carrying weapons in the coming days, officials say, a major shift that comes days after President Trump ...

Homelessness minister Rushanara Ali has been forced to resign after it was alleged that she "ejected" tenants from one of her properties.

Stock futures were rising again on the eve of another tariff deadline as investors juggled strong earnings with more signs of U.S. economic weakness. Shares closed in the red Tuesday after the ISM ...

a retired cardiologist and corresponding member of the faculty of medicine at the Beth Israel Deaconess Medical Center. The ...

The Score is a weekly review of the biggest stock moves and the news that drove them. Whirlpool expects its performance to spin back around soon. The appliance maker on Monday cut its full-year profit ...

This morning, BHP has reported an 8% decline in full-year revenues to US$51.3b. Underlying earnings fell 26% to US$10.2 billion. Weaker prices for iron ore and coal (and better copper prices) were the ...

Novo Nordisk said on Friday the US Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...